Valeo Financial Advisors’s Avanos Medical AVNS Stock Holding History

Valeo Financial Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12	Closed	-$1K	–	2016
2020 Q4	$1K	Hold	12	–	–	﹤0.01%	1559
2020 Q3	$0	Sell	12 -6	-33%	-$192	﹤0.01%	1611
2020 Q2	$1K	Buy	+18	New	+$521	﹤0.01%	1846
2019 Q3	–	Sell	-150	Closed	-$7K	–	1551
2019 Q2	$7K	Hold	150	–	–	﹤0.01%	1108
2019 Q1	$6K	Hold	150	–	–	﹤0.01%	1082
2018 Q4	$7K	Sell	150 -15	-9%	-$786	﹤0.01%	964
2018 Q3	$9K	Buy	165 +15	+10%	+$965	﹤0.01%	990
2018 Q2	$9K	Sell	150 -150	-50%	-$7.93K	﹤0.01%	956
2018 Q1	$14K	Hold	300	–	–	﹤0.01%	825
2017 Q4	$14K	Hold	300	–	–	﹤0.01%	744
2017 Q3	$14K	Buy	+300	New	+$12.8K	﹤0.01%	624

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Valeo Financial Advisors's AVNS Position: Q1 2021 in Review

Valeo Financial Advisors sold out of Avanos Medical (AVNS) in Q1 2021, closing a stake of 12 shares — an estimated $1K sold.

Valeo Financial Advisors first reported a position in AVNS in Q3 2017 and held it in 11 quarters. The position peaked at $14K in Q1 2018. 291 funds tracked by Wall St. Rank hold AVNS as of Q1 2021.

Valeo Financial Advisors reported no remaining Avanos Medical position as of Q1 2021 after selling out during the quarter.
Valeo Financial Advisors sold 12 Avanos Medical shares in Q1 2021, an estimated $1K.
Valeo Financial Advisors first reported a position in Avanos Medical in Q3 2017 and held it in 11 quarters.
Valeo Financial Advisors's Avanos Medical position peaked at $14K in Q1 2018.
291 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2021.

Based on Valeo Financial Advisors's 13F filing for Q1 2021, filed 12 Apr 2021.